Dolby Laboratories (NYSE:DLB) Major Shareholder Dagmar Dolby Sells 100,000 Shares

Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 100,000 shares of the firm’s stock in a transaction dated Monday, August 28th. The shares were sold at an average price of $49.98, for a total value of $4,998,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Wednesday, August 30th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.51, for a total value of $4,951,000.00.
  • On Wednesday, August 23rd, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.00, for a total value of $2,450,000.00.
  • On Thursday, August 24th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.98, for a total value of $4,898,000.00.
  • On Tuesday, August 22nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.28, for a total value of $4,828,000.00.
  • On Friday, August 18th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $48.82, for a total value of $4,882,000.00.
  • On Wednesday, August 16th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $49.71, for a total value of $4,971,000.00.
  • On Monday, August 14th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.19, for a total value of $5,019,000.00.
  • On Wednesday, August 9th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.20, for a total value of $2,560,000.00.
  • On Thursday, August 10th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $50.84, for a total value of $5,084,000.00.
  • On Monday, August 7th, Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock. The stock was sold at an average price of $51.26, for a total value of $2,563,000.00.

Dolby Laboratories (NYSE:DLB) traded up 8.797% during midday trading on Wednesday, hitting $58.685. The stock had a trading volume of 1,661,844 shares. Dolby Laboratories has a 12 month low of $44.99 and a 12 month high of $59.34. The company has a market cap of $6.02 billion, a P/E ratio of 30.018 and a beta of 0.81. The firm’s 50-day moving average price is $50.68 and its 200 day moving average price is $50.92.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings data on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.10. Dolby Laboratories had a return on equity of 10.25% and a net margin of 19.02%. The business had revenue of $305.67 million during the quarter, compared to analysts’ expectations of $296.88 million. During the same quarter last year, the business posted $0.62 EPS. The business’s revenue was up 10.1% on a year-over-year basis. On average, analysts expect that Dolby Laboratories will post $1.99 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Tuesday, August 15th. Stockholders of record on Monday, August 7th were given a $0.14 dividend. This represents a $0.56 annualized dividend and a dividend yield of 1.04%. The ex-dividend date of this dividend was Thursday, August 3rd. Dolby Laboratories’s dividend payout ratio is currently 28.57%.

ILLEGAL ACTIVITY WARNING: “Dolby Laboratories (NYSE:DLB) Major Shareholder Dagmar Dolby Sells 100,000 Shares” was originally posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this article on another publication, it was illegally copied and republished in violation of United States & international trademark and copyright law. The legal version of this article can be read at https://stocknewstimes.com/2017/09/13/insider-selling-dolby-laboratories-dlb-major-shareholder-sells-100000-shares-of-stock.html.

Several large investors have recently made changes to their positions in DLB. Watermark Asset Management Inc. bought a new position in shares of Dolby Laboratories in the 1st quarter worth approximately $114,000. Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of Dolby Laboratories by 9.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,331 shares of the electronics maker’s stock worth $114,000 after acquiring an additional 209 shares in the last quarter. US Bancorp DE raised its position in shares of Dolby Laboratories by 2.6% in the 2nd quarter. US Bancorp DE now owns 3,029 shares of the electronics maker’s stock worth $149,000 after acquiring an additional 78 shares in the last quarter. James Investment Research Inc. bought a new position in shares of Dolby Laboratories in the 1st quarter worth approximately $155,000. Finally, The Manufacturers Life Insurance Company raised its position in shares of Dolby Laboratories by 25.5% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,564 shares of the electronics maker’s stock worth $174,000 after acquiring an additional 725 shares in the last quarter. 51.88% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have recently issued reports on DLB. BidaskClub downgraded Dolby Laboratories from a “hold” rating to a “sell” rating in a research report on Saturday, June 10th. B. Riley restated a “dlb (” rating and set a $61.50 price objective on shares of Dolby Laboratories in a research report on Friday, August 18th. Piper Jaffray Companies restated a “neutral” rating and set a $52.00 price objective (up from $49.00) on shares of Dolby Laboratories in a research report on Wednesday. Finally, Zacks Investment Research upgraded Dolby Laboratories from a “sell” rating to a “hold” rating in a research report on Tuesday, July 4th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $55.88.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply